Replies to post #77 on Synageva BioPharma (GEVA)

[Peter2004]

How does this merger impact TRMS? What is the value of TRMS after merger? TIA.

[surf1944]

Synageva BioPharma(GEVA_), a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for patients with rare diseases and unmet medical needs. This stock is trading down 0.40% to $17.50 in recent trading, after it hit a 52-week high of $17.70 earlier today.

Today's Range: $17.50-$17.70

52-week Range: $8.30-$17.70

Volume: 2,845

Three-Month Average Volume: 21,678

Synageva BioPharma has a market cap of $307.9 million This stock trades at a price-to-sales of 30.62. The current short interest as a percentage of the float for Synageva is notable at 4.8%.


http://www.thestreet.com/_yahoo/story/11329209/1/6-stocks-hitting-new-52-week-highs.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NA